News

The latest news from the MCDS-Therapy team.

Successful first annual meeting in Bologna!

Representatives of our 11 partners gathered in Bologna for the first annual meeting, 29-30th October. What happens you combine 24 scientists, clinicians, clinical trial officers, charity workers and professional organisers with the finest tagliatelle…

Why are we doing biomarker discovery?

What is a biomarker and why is the MCDS-Therapy team trying to find one? Sciomics, the partner focusing on this part of our work, have written this handy blog to keep you in-the-know. Having a rare disease is challenging for patients…

MCDS presented for the first time

Professor Mike Briggs presented the work behind MCDS-Therapy at Findacure’s Drug Repurposing for Rare Diseases conference. As an academic-led, industry-free drug repurposing project for an ultra-rare disease, the MCDS-Therapy team is keen…

Kick-off meeting

The 11 partners of MCDS-Therapy met in Brussels to officially launch the project. The MCDS-Therapy project is off to a great start. Having been awarded a grant of €5,700,000 from the European Union’s Horizon 2020 fund in December 2017,…

H2020 grant success!

The MCDS-Therapy project has been awarded €5,700,000 from the European Union’s Horizon 2020 fund. The MCDS-Therapy project has received the fantastic news that our application to the European Union’s Horizon 2020 fund has been successful.…